EMZELBI
LIVE

Serial Number

79313584

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Apr 30, 2021

Add to watchlist:

No watchlists yet
View on USPTO

EMZELBI Trademark

Serial Number: 79313584 • Registration: 7203745

EMZELBI is a trademark filed by NOVARTIS AG on April 30, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,166 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

April 30, 2021

Registration Date

October 31, 2023

Published for Opposition

August 15, 2023

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 31, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 31, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 15, 2023 NPUB
PUBLISHED FOR OPPOSITION
Aug 15, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Aug 13, 2023 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 26, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 26, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 26, 2023 NONP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 16, 2023 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 19, 2023 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 19, 2023 OPNR
FINAL DISPOSITION REVIEWED - NO ACTION REQUIRED BY OFFICE
Jun 15, 2022 FINA
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Jun 15, 2022 CORN
REG. CANCELLED - RESTORED TO PENDENCY
Mar 9, 2022 CRTP
ASSIGNED TO PETITION STAFF
Mar 9, 2022 APET
REQUEST TO CANCEL INADVERTENTLY ISSUED REGISTRATION RECEIVED
Mar 8, 2022 RCII
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Feb 3, 2022 GPAR
TEAS SECTION 7 REQUEST RECEIVED
Jan 31, 2022 ES7R
REGISTERED-PRINCIPAL REGISTER
Jan 4, 2022 R.PR
CORRECTION TRANSACTION RECEIVED FROM IB
Nov 23, 2021 CRCV
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 19, 2021 NPUB
PUBLISHED FOR OPPOSITION
Oct 19, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 29, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 16, 2021 CNSA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 16, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 15, 2021 TCCA
ASSIGNED TO EXAMINER
Sep 9, 2021 DOCK
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 9, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 9, 2021 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jul 9, 2021 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 9, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 9, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 9, 2021 COAR
APPLICATION FILING RECEIPT MAILED
Jul 1, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 27, 2021 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jun 26, 2021 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Jun 17, 2021 SDRC